These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 6757955

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Rapidly progressive glomerulonephritis].
    Harada T, Ozono Y, Kawatomi M, Hara K.
    Nihon Rinsho; 1992 Jan; 50 Suppl():134-8. PubMed ID: 1578668
    [No Abstract] [Full Text] [Related]

  • 23. [Nephrology update--IV. Rapidly progressing glomerulonephritis].
    Fünfstück R, Stein G.
    Med Klin (Munich); 1996 Oct 15; 91(10):632-9. PubMed ID: 9019640
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells.
    House AK, Boak JL, Hulme B.
    Clin Exp Immunol; 1972 Jun 15; 11(2):165-72. PubMed ID: 4557180
    [Abstract] [Full Text] [Related]

  • 26. Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis.
    Grcevska L, Polenaković M, Stojkovski L, Polenaković H.
    Artif Organs; 1998 Oct 15; 22(10):827-30. PubMed ID: 9790079
    [Abstract] [Full Text] [Related]

  • 27. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ, Moorthy AV, Beirne GJ.
    Clin Nephrol; 1980 Feb 15; 13(2):97-102. PubMed ID: 7363520
    [Abstract] [Full Text] [Related]

  • 28. Human renal transplants. II. Immunofluorescent and immunoferritin studies.
    Porter KA, Andres GA, Calder MW, Dossetor JB, Hsu KC, Rendall JM, Seegal BC, Starzl TE.
    Lab Invest; 1968 Feb 15; 18(2):159-71. PubMed ID: 4171297
    [No Abstract] [Full Text] [Related]

  • 29. [Plasma exchange in progressive lupus nephritis].
    Hörmann A, Keusch G, Burger R, Briner J, Binswanger U, Gmür J.
    Schweiz Med Wochenschr; 1982 Jun 12; 112(24):853-8. PubMed ID: 7112055
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr 12; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 32. Recurrent and de novo glomerulonephritis postrenal transplantation.
    Guttmann RD.
    Transplant Proc; 1996 Jun 12; 28(3):1168-70. PubMed ID: 8658613
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic apheresis in renal and metabolic diseases.
    Winters JL, Pineda AA, McLeod BC, Grima KM.
    J Clin Apher; 2000 Jun 12; 15(1-2):53-73. PubMed ID: 10767051
    [No Abstract] [Full Text] [Related]

  • 34. [Therapy of acute glomerulonephritis].
    Stirati G, Manzi M.
    Clin Ter; 1981 Mar 15; 96(5):539-52. PubMed ID: 7285523
    [No Abstract] [Full Text] [Related]

  • 35. [Anti-GBM glomerulonephritis and RPGN].
    Shimizu Y, Tomino Y.
    Nihon Jinzo Gakkai Shi; 2009 Mar 15; 51(2):94-7. PubMed ID: 19378793
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Diabetic woman with massive proteinuria and acute renal failure.
    Nair R, Said M.
    Am J Kidney Dis; 2005 Aug 15; 46(2):362-6. PubMed ID: 16112058
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.
    Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM.
    Kidney Int; 1991 Oct 15; 40(4):757-63. PubMed ID: 1745027
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.